490 BioTech is a small business with a big mission. We have developed a technology called autobioluminescence that enables any cell to self-produce a harmless visible light signal that either continuously and automatically adjusts in intensity to reflect the host’s real-time metabolic activity level or can turn itself on or off in response to target biomarker expression. This technology allows pharma and CROs to observe real-time cellular responses at a fraction of the cost of existing technologies without necessitating investment in new equipment or protocols. We are using this technology to develop a new generation of discovery and pre-clinical assay tools that provide better quality and more informative data so that our users can streamline their development pipelines and focus their efforts on only those compounds most likely to excel during clinical trials. Our mission is to make it easier for our customers to change the world for the better.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Autobioluminescent Screening Platform
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):